Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

2.

Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.

Colwell CW Jr, Spiro TE, Trowbridge AA, Morris BA, Kwaan HC, Blaha JD, Comerota AJ, Skoutakis VA.

J Bone Joint Surg Am. 1994 Jan;76(1):3-14. Erratum in: J Bone Joint Surg Am 1994 Mar;76(3):4741.

PMID:
8288662
3.

Enoxaparin in the prevention of deep venous thrombosis.

Ament PW, Bertolino JG.

Am Fam Physician. 1994 Dec;50(8):1763-8. Review.

PMID:
7977005
4.

Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement.

Planes A, Vochelle N, Mazas F, Mansat C, Zucman J, Landais A, Pascariello JC, Weill D, Butel J.

Thromb Haemost. 1988 Dec 22;60(3):407-10.

PMID:
2853459
5.

Efficacy and safety of enoxaparin to prevent deep vein thrombosis after hip arthroplasty.

Colwell CW Jr, Spiro TE.

Clin Orthop Relat Res. 1995 Oct;(319):215-22.

PMID:
7554633
6.
7.
8.

Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group.

Comp PC, Spiro TE, Friedman RJ, Whitsett TL, Johnson GJ, Gardiner GA Jr, Landon GC, Jové M; Enoxaparin Clinical Trial Group.

J Bone Joint Surg Am. 2001 Mar;83-A(3):336-45.

PMID:
11263636
9.

Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty. Enoxaparin Clinical Trial Group.

Colwell CW Jr, Spiro TE, Trowbridge AA, Stephens JW, Gardiner GA Jr, Ritter MA.

Clin Orthop Relat Res. 1995 Dec;(321):19-27.

PMID:
7497668
10.

A meta-analysis of methods to prevent venous thromboembolism following total hip replacement.

Imperiale TF, Speroff T.

JAMA. 1994 Jun 8;271(22):1780-5. Erratum in: JAMA 1995 Jan 25;273(4):288.

PMID:
7515115
11.
12.

[Comparison between low-molecular and unfractionated heparin in the prevention of thrombosis in patients with total endoprosthetic replacement of hip and knee joint].

Rader CP, Kramer C, König A, Gohlke F, Eulert J.

Z Orthop Ihre Grenzgeb. 1997 Jan-Feb;135(1):52-7. German.

PMID:
9199074
13.

Prophylaxis for the prevention of venous thromboembolism after total knee arthroplasty. A comparison between unfractionated and low-molecular-weight heparin.

Faunø P, Suomalainen O, Rehnberg V, Hansen TB, Krøner K, Soimakallio S, Nielsen E.

J Bone Joint Surg Am. 1994 Dec;76(12):1814-8.

PMID:
7989386
14.

Reviparin: a review of its efficacy in the prevention and treatment of venous thromboembolism.

Wellington K, McClellan K, Jarvis B.

Drugs. 2001;61(8):1185-209. Review.

PMID:
11465877
15.

Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.

Leyvraz PF, Bachmann F, Hoek J, Büller HR, Postel M, Samama M, Vandenbroek MD.

BMJ. 1991 Sep 7;303(6802):543-8. Erratum in: BMJ 1991 Nov 16;303(6812);1243.

16.

A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery.

Turpie AG, Levine MN, Hirsh J, Carter CJ, Jay RM, Powers PJ, Andrew M, Hull RD, Gent M.

N Engl J Med. 1986 Oct 9;315(15):925-9.

PMID:
3531851
19.

[Double-blind randomized comparative study of enoxaparin and standard heparin in the prevention of thromboembolic disease during insertion of total hip replacement].

Planes A, Vochelle N, Mazas F, Mansat C, Zucman G, Landais A, Weill D, Pascariello JC, Butel J.

Rev Med Interne. 1988 May-Jun;9(3):327-33. French.

PMID:
2841742
20.

[Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin].

Marx A, Huhle G, Hoffmann U, Wang LC, Schüle B, Jani L, Harenberg J.

Z Orthop Ihre Grenzgeb. 1999 Nov-Dec;137(6):536-9. German.

PMID:
10666863

Supplemental Content

Support Center